Karine Alcala

Centre international de recherche sur le cancer

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The blood proteome of imminent lung cancer diagnosis”.

The blood proteome of imminent lung cancer diagnosis

Nature Communications(2023)10.1038/s41467-023-37979-8

N/A

0.659DataRank · unranked

80 citations

Karine Alcala, Nicolas Alcala, Christopher I. Amos, Alan A. Arslan, Julie K. Bassett +33 more

Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

British Journal of Cancer(2021)10.1038/s41416-021-01278-0

N/A

0.635DataRank · unranked

68 citations

Karine Alcala, Anthony J. Swerdlow, Minouk J. Schoemaker, Nick Wareham, Ruth C. Travis +6 more

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Annals of Epidemiology(2022)10.1016/j.annepidem.2022.10.014

N/A

0.524DataRank · unranked

32 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +51 more

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

medRxiv(2022)10.1101/2022.03.21.22272544

N/A

0.208DataRank · unranked

3 citations

Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed +50 more

IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor Expression

medRxiv(2021)10.1101/2021.03.26.21254400

N/A

0.165DataRank · unranked

2 citations

Yan Chen, Linda Kachuri, Pooja Middha, Florence Guida, Hana Zahed +22 more

Regular use of pharmaceutical opioids and subsequent risk of cancer: a prospective cohort study and Mendelian randomization analysis

EClinicalMedicine(2025)10.1016/j.eclinm.2025.103439

N/A

0DataRank · unranked

2 citations

Allison Domingues, Karine Alcala, Ryan Langdon, Daniela Mariosa, Xiaoshuang Feng +24 more

Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.102229

N/A

0DataRank · unranked

19 citations

Hossein Poustchi, Vivian Viallon, Farhad Islami, Akram Pourshams, Alireza Sadjadi +14 more

Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad071

N/A

0DataRank · unranked

23 citations

Wendy Wu, Justina Ucheojor Onwuka, Z. Haider, Karine Alcala, Karl Smith‐Byrne +33 more

Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis

EBioMedicine(2023)10.1016/j.ebiom.2023.104623

N/A

0DataRank · unranked

3 citations

David C. Muller, Hana Zahed, Karine Alcala, Florence Guida, Karl Smith-Byrne +16 more

Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study

EClinicalMedicine(2025)10.1016/j.eclinm.2025.103152

N/A

0DataRank · unranked

7 citations

Hana Zahed, Xiaoshuang Feng, Karine Alcala, Loretta Erhunmwunsee, Randi M. Williams +36 more